Saturn V Capital Management LP Diversified Active

Location: Austin, TX

CIK: 0001964437 · Show all filings

Period: Q4 2022 (Next →)

Filing Date: Feb 9, 2023

Total Value: $121M (100.0% shares, 0.0% debt)

Holdings (19)

CRNX CRINETICS PHARMACEUTICALS IN 9.4%

Value $11.34M Shares 623,819 Est. Cost $17.62 Unrealized 0.0%

— 2SEVENTY BIO INC 8.2%

Value $9.886M Shares 684,996 Est. Cost $14.43 Unrealized —

APLS APELLIS PHARMACEUTICALS INC 7.8%

Value $9.414M Shares 212,329 Est. Cost $53.04 Unrealized 0.0%

ARQT ARCUTIS BIOTHERAPEUTICS INC 7.3%

Value $8.787M Shares 487,179 Est. Cost $17.47 Unrealized 0.0%

CYTK CYTOKINETICS INC 6.6%

Value $7.974M Shares 196,982 Est. Cost $42.95 Unrealized 0.0%

ASND ASCENDIS PHARMA A/S 6.6%

Value $7.954M Shares 68,404 Est. Cost $116.28 Unrealized —

— MORPHIC HLDG INC 6.1%

Value $7.373M Shares 269,827 Est. Cost $27.33 Unrealized —

— ITEOS THERAPEUTICS INC 5.8%

Value $7.028M Shares 342,071 Est. Cost $20.55 Unrealized —

— ALBIREO PHARMA INC 5.7%

Value $6.865M Shares 341,827 Est. Cost $20.08 Unrealized —

— CHINOOK THERAPEUTICS INC 5.6%

Value $6.728M Shares 423,177 Est. Cost $15.90 Unrealized —

KALV KALVISTA PHARMACEUTICALS INC 5.6%

Value $6.697M Shares 719,937 Est. Cost $5.36 Unrealized 0.0%

— CYMABAY THERAPEUTICS INC 4.7%

Value $5.718M Shares 1,611,778 Est. Cost $3.55 Unrealized —

— HORIZON THERAPEUTICS PLC 4.7%

Value $5.681M Shares 69,170 Est. Cost $82.13 Unrealized —

— SAGE THERAPEUTICS INC 4.5%

Value $5.368M Shares 156,085 Est. Cost $34.39 Unrealized —

FOLD AMICUS THERAPEUTICS INC 4.1%

Value $4.893M Shares 566,179 Est. Cost $11.26 Unrealized 0.0%

BCRX BIOCRYST PHARMACEUTICALS INC 3.1%

Value $3.751M Shares 340,163 Est. Cost $12.47 Unrealized 0.0%

BIIB BIOGEN INC 1.8%

Value $2.17M Shares 7,660 Est. Cost $282.44 Unrealized 0.0%

— ASTRIA THERAPEUTICS INC 1.3%

Value $1.557M Shares 169,493 Est. Cost $9.18 Unrealized —

TBPH THERAVANCE BIOPHARMA INC 1.1%

Value $1.334M Shares 141,339 Est. Cost $10.51 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
CRNX	CRINETICS PHARMACEUTICALS IN	623,819	$11.34M	9.4%	$17.62	0.0%	Common	22663K107
—	2SEVENTY BIO INC	684,996	$9.886M	8.2%	$14.43	—	Common	901384107
APLS	APELLIS PHARMACEUTICALS INC	212,329	$9.414M	7.8%	$53.04	0.0%	Common	03753U106
ARQT	ARCUTIS BIOTHERAPEUTICS INC	487,179	$8.787M	7.3%	$17.47	0.0%	Common	03969K108
CYTK	CYTOKINETICS INC	196,982	$7.974M	6.6%	$42.95	0.0%	Common	23282W605
ASND	ASCENDIS PHARMA A/S	68,404	$7.954M	6.6%	$116.28	—	Sponsored ADR	04351P101
—	MORPHIC HLDG INC	269,827	$7.373M	6.1%	$27.33	—	Common	61775R105
—	ITEOS THERAPEUTICS INC	342,071	$7.028M	5.8%	$20.55	—	Common	46565G104
—	ALBIREO PHARMA INC	341,827	$6.865M	5.7%	$20.08	—	Common	01345P106
—	CHINOOK THERAPEUTICS INC	423,177	$6.728M	5.6%	$15.90	—	Common	16961L106
KALV	KALVISTA PHARMACEUTICALS INC	719,937	$6.697M	5.6%	$5.36	0.0%	Common	483497103
—	CYMABAY THERAPEUTICS INC	1,611,778	$5.718M	4.7%	$3.55	—	Common	23257D103
—	HORIZON THERAPEUTICS PLC	69,170	$5.681M	4.7%	$82.13	—	SHS	G46188101
—	SAGE THERAPEUTICS INC	156,085	$5.368M	4.5%	$34.39	—	Common	78667J108
FOLD	AMICUS THERAPEUTICS INC	566,179	$4.893M	4.1%	$11.26	0.0%	Common	03152W109
BCRX	BIOCRYST PHARMACEUTICALS INC	340,163	$3.751M	3.1%	$12.47	0.0%	Common	09058V103
BIIB	BIOGEN INC	7,660	$2.17M	1.8%	$282.44	0.0%	Common	09062X103
—	ASTRIA THERAPEUTICS INC	169,493	$1.557M	1.3%	$9.18	—	Common	04635X102
TBPH	THERAVANCE BIOPHARMA INC	141,339	$1.334M	1.1%	$10.51	0.0%	Common	G8807B106